Cytokines in neuroinflammatory disease: role of myelin autoreactive T cell production of interferon-gamma

https://doi.org/10.1016/0165-5728(92)90135-8Get rights and content

Abstract

Many cytokines must be considered as effector and immunoregulatory molecules in neuroinflammatory diseases such as multiple sclerosis (MS) and experimental allergic encephalomyelitis (EAE). We have studied the potential role of interferon-gamma (IFN-γ) in the pathogenesis of these diseases, since this cytokine has a number of important effects such as macrophage activation, induction of MHC class I and class I antigens, and T cell homing. An immunospot assay that allows enumeration of single cells secreting IFN-γ after short-term culture in vitro of mononuclear cell suspensions has been used. In EAE, increased numbers of IFN-γ-secreting cells (IFN-γ-sc) appear in the central nervous system shortly before onset of clinical signs. Such cells also increased during pharmacologically induced relapse of EAE. In later stages of EAE, memory T cells that produced IFN-γ in response to presented antigen, recognized multiple regions of the myelin basic protein (MBP), showing that (i) myelin autoreactive T cells have the functional ability to produce this cytokine, (ii) the concept of immunodominance as to autoantigen peptide reactivity is non-absolute and time-dependent. In multiple sclerosis (MS) there are increased numbers of IFN-γ-sc among the CSF cells. Also, there are increased numbers of memory T cells, strongly enriched to the cerebrospinal fluid, which upon recognition of several myelin antigens and several MBP peptide stretches, produce IFN-γ. Taken together, the data are consistent with a role for IFN-γ as a key mediator in inflammatory demyelinating diseases.

References (51)

  • R.D. Simmons et al.

    Direct injection of cytokines into the spinal cord causes autoimmune encephalomyelitis-like inflammation

    J. Neurol. Sci.

    (1990)
  • B. Steiniger et al.

    Rat ependyma and microglia cells express class II MHC antigens after intravenous infusion of recombinant gamma interferon

    J. Neuroimmunol.

    (1988)
  • P.H. Van der Meide et al.

    Assessment of the inhibitory effect of immunosuppressive agents on rat T cell interferon-γ production using an ELISPOT assay

    J. Immunol. Methods

    (1991)
  • D.O. Adams et al.

    Molecular transductional mechanisms by which IFN-γ and other signals regulate macrophage development

    Immunol. Rev.

    (1987)
  • M. Bakhiet et al.

    Depletion of CD8+ T cells suppresses growth of Trypanosoma brucei brucei and IFN-γ production in infected rats

    Clin. Exp. Immunol.

    (1990)
  • I. Chrétien et al.

    Regulation of human IgE synthesis. I. Human IgE synthesis in vitro is determined by the reciprocal antagonistic effects of interleukin 4 and interferon-γ

    Eur. J. Immunol.

    (1990)
  • I.Y. Chung et al.

    Differential tumor necrosis factor α expression by astrocytes from experimental allergic encephalomyelitis — susceptible and resistant rat strains

    J. Exp. Med.

    (1991)
  • M.A. Collart et al.

    Gamma-interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin-1, and uronkinase genes, which are controlled by short-lived repressors

    J. Exp. Med.

    (1986)
  • A.M. Duijvestijn et al.

    Interferon-gamma regulates an antigen specific for endothelial cells involved in lymphocyte traffic

  • W. Fierz et al.

    Astrocytes as antigen-presenting cells. I. Induction of Ia antigen expression on astrocytes by T cells via immune-interferon, and its effect on antigen presentations

    J. Immunol.

    (1985)
  • K. Frei et al.

    Interleukin-6 is elevated in plasma in multiple sclerosis

    J. Neuroimmunol.

    (1991)
  • M. Goldberg et al.

    Regulation of macrophage function by interferon-γ. Somatic cell genetic approaches in murine macrophage cell lines to mechanisms of growth inhibition, the oxidative burst, and expression of the chronic granulomatous disease gene

    J. Clin. Invest.

    (1990)
  • K.T. Hayglass et al.

    Anti-interferon treatment blocks the ability of glutaraldehyde-polymerized allergens to inhibit specific IgE responses

    J. Exp. Med.

    (1991)
  • T.T. Hecht et al.

    The relationship between immune interferon production and proliferation in antigen-specific, MHC-restricted T cell lines and clones

    J. Immunol.

    (1983)
  • F. Heinzel et al.

    Reciprocal expression of interferon γ or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cells

    J. Exp. Med.

    (1989)
  • Cited by (131)

    • Dysfunction of CD3<sup>−</sup>CD16<sup>+</sup>CD56<sup>dim</sup> and CD3<sup>−</sup>CD16<sup>−</sup>CD56<sup>bright</sup> NK cell subsets in RR-MS patients

      2018, Clinical Immunology
      Citation Excerpt :

      Also, investigation of NKR expression profiles in association with disease duration might provide another perspective in MS pathogenesis. IFN-γ plays important roles in autoimmune diseases and for years, IFN-γ producing Th1 cells have been claimed as plausible pathogenic factors for MS development [36,37]. CD3−CD16+CD56dim NK cells are known to be the early producers of IFN-γ upon stimulation and their IFN-γ levels were reported to be decreased after 16 h [38], whereas CD3−CD16−CD56bright NK cells secrete large amounts of IFN-γ even after days.

    • The tolerogenic role of IFN-γ

      2018, Cytokine and Growth Factor Reviews
      Citation Excerpt :

      This coincides with our current understanding of EAE pathology (as well as that of multiple sclerosis (MS)), which involves several immune cell types of both innate and adaptive immunity, although pathogenic Th1 and Th17 clones seem to play the most fundamental roles. Initially, it was accepted that pathogenic Th1 cell clones are the main cause of disease initiation and progression [40,41]. We now know that Th17 effector cells also play a pivotal role in EAE and MS, as well as in various other ADs [42,43].

    View all citing articles on Scopus
    View full text